The Effect Of Medical Nutritional Therapy On Patients With Sarcopenic Obesity Receiving Peritoneal Dialysis Treatment
NCT ID: NCT05797181
Last Updated: 2024-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2023-02-07
2023-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of a Plant-Focused Diet on Nutritional Status in Malnourished Peritoneal Dialysis Patients
NCT07157397
Effects of Intradialytic Exercise on Muscle Oxygenation and Dialysis Adequacy
NCT07151742
Fluid Overload in Peritoneal Dialysis
NCT02557347
A Novel Equation for Estimating Sodium Intake in Peritoneal Dialysis.
NCT05955417
Comparison of the Effectiveness of Intradialytic Core Stabilization and Aerobic Exercise in Hemodialysis Patients
NCT05534542
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dietary and Behavioral Change Group
The experimental group will be required to adhere to a diet consisting of a 10-15% reduction in carbohydrate and a 1.2-1.4 g/kg body weight/day intake of protein.
The participants will receive 4 times face-to-face meetings (on the first day and on week 1,5 and 9).
Each face-to-face interview will last approximately 30 minutes. During the interview researcher will help the participants to determine their nutritional behaviors, plan and implement the diet.
medical nutrition therapy in kidney diseases
Planning and implementation of diets containing high protein, low potassium, low phosphorus, personalized adjusted carbohydrates
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
medical nutrition therapy in kidney diseases
Planning and implementation of diets containing high protein, low potassium, low phosphorus, personalized adjusted carbohydrates
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be between the ages of 18-70
* To receive peritoneal dialysis treatment and to come to the hospital regularly once a month for treatment
Exclusion Criteria
* Patients using any supplement or enteral product in their diet
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Atlas University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ayşe Betül Demirbaş
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ayşe Betül Demirbaş
Role: PRINCIPAL_INVESTIGATOR
Atlas University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Marmara University
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ABDemirbasPD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.